BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2015
View Archived Issues
Col-Treg designated by the FDA as orphan drug for the treatment of chronic non-infectious uveitis
Read More
Promising phase II results on lenvatinib in advanced medullary thyroid cancer
Read More
TC Biopharm granted CTA approval to treat cancer patients with ImmuniCell
Read More
Protalix reports positive data from second dose cohort in phase I/II trial of PRX-102
Read More
NCI grant supports planned phase II study of Yeliva for refractory or relapsed multiple myeloma
Read More
New approaches identified for Middle-East respiratory syndrome coronavirus vaccination
Read More
Next-generation CDK2/9 inhibitor CCT-68127 shows potent activity against lung cancer cells
Read More
Phase I findings confirm bioavailability of Gordagen's MELT3 formulation
Read More
FDA accepts IND and grants orphan drug designation to DTX-101 for hemophilia B
Read More
FDA grants fast track designation to MN-001 for IPF
Read More
Amgen seeks FDA approval for new delivery option for monthly administration of Repatha
Read More
AR-301 gets FDA fast track designation for acute pneumonia caused by S. aureus
Read More
Blueprint Medicines cleared to study BLU-285 in systemic mastocytosis
Read More
SK Biopharmaceuticals discovers dopamine reuptake inhibitors
Read More
Vaccibody starts phase I/IIa trial of VB10.16 in women with cervical intraepithelial neoplasia
Read More
Nimbus Lakshmi introduces TYK2 and JAK2 inhibitors
Read More
Gilead patent discloses compounds for the treatment of HIV
Read More
BioCancell's BC-819 receives FDA fast track designation in bladder cancer
Read More
Treventis reports beta-amyloid aggregation inhibitors
Read More
EMA grants orphan drug designation to Stemline's SL-401 for AML
Read More
FDA advisory committees recommend approval of Collegium's Xtampza ER
Read More
FDA approves Humira for moderate to severe hidradenitis suppurativa
Read More
HUHS-1015 potently inhibits malignant mesothelioma cell proliferation
Read More
FDA accepts first NDA for a digital medicine
Read More
Novel PI4K2A gene mutations identified in cutis laxa syndrome with choreoathetosis
Read More